Sigrid Therapeutics
Oral porous silica to treat obesity
This article was originally published in Start Up
Executive Summary
Sigrid Therapeutics was spun out from Stockholm-based Nanologica AB to develop treatments for obesity. The start-up’s lead project is an oral formulation of porous silica designed to reduce the absorption of fat from food and help people with a BMI of more than 30 to lose weight.